the new epilepsy drug, Potiga (poe-TEE-ga, ezogabine)

Please see the October 2013 FDA Drug Safety Communication regarding Potiga and skin discoloration/retinal abnormalities

You'll soon see the new epilepsy drug, Potiga (poe-TEE-ga, ezogabine), hit your pharmacy.

Don't expect Potiga to fly off your shelves. It's dosed THREE times a day...costs over $700/month...and comes with some unusual side effects.

Give out a with outpatient Rxs...to meet the Risk Evaluation and Mitigation Strategies (REMS) program requirement for alerting patients to Potiga's risk of causing urinary problems.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote